Marriage Counselors in North Haven, CT Accepting Medicare

7 Marriage Counselors found. Showing 1 - 7

Heather Lavallee Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 Washington Ave, North Haven, CT 06473 Phone: 203-228-8423

Mrs. Linda A. Zunda, M.S., L.M.F.T. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 72 Upper State St, North Haven, CT 06473 Phone: 203-234-0777

Christine Silva Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 262 State St Ste C, North Haven, CT 06473 Phone: 203-408-2146

Mrs. Irena Taylor, MS MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 83 Bradley St, North Haven, CT 06473 Phone: 203-234-1340    Fax: 203-234-2389

Ms. Michelle Jean Piccerillo, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 221 Borrelli Rd, North Haven, CT 06473 Phone: 203-234-8374

Ms. Deborah A Kornitsky Pausig Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5 Roger Ave, North Haven, CT 06473 Phone: 203-239-3487

Ms. Melinda Elizabeth Pritz, M.A., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 83 Bradley St, North Haven, CT 06473 Phone: 203-234-1340    Fax: 203-234-2389

News Archive

Pharmaceutical industry to execute new strategies in the coming year

As they pop the champagne corks to celebrate New Year's Eve, drug industry executives will likely be glad to put 2009 behind them. That's because pharmaceutical companies who make top-selling drugs for heart disease, asthma, and many other conditions had a tough year in the midst of mounting market pressures and a global recession.

Abbott and BG Medicine announce a development and commercialization agreement for galectin-3 biomarker

Abbott and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott's ARCHITECT immunochemistry instrument platform, specifically the company's i1000SR and i2000SR instruments. The agreement grants Abbott a license to BG Medicine's intellectual property related to galectin-3.

BUSM researchers participate in five-year program to develop biomarkers for small vessel disease

To better predict, study and diagnose small vessel disease in the brain and its role in vascular contributions to cognitive impairment and dementia (VCID), Boston University School of Medicine has been selected to participate in MarkVCID, a consortium designed to accelerate the development of new and existing biomarkers for small vessel VCID.

COBRA, Medicaid subsidies still loom over Congressional agenda

Kaiser Health News staff writer Andrew Villegas provides a status update regarding key health-related legislation:

Read more Medical News

› Verified 9 days ago